{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:28:56Z","timestamp":1793654936332,"version":"4.5.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"American Psychological Association Minority Fellowship Program","award":["American Psychological Association Minority Fellowship Program"],"award-info":[{"award-number":["American Psychological Association Minority Fellowship Program"]}],"id":[{"id":"https:\/\/ror.org\/00rt1d436","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>HIV is a pressing global public health problem, with marked disparities among adults who engage in injection drug use (IDU). Despite the development and implementation of highly effective HIV prevention and treatment options, utilization and adherence are still low among those at increased risk, such as those who inject drugs. Stigma may be a significant barrier to accessing care across the HIV prevention and treatment care continuums and may be associated with poorer health outcomes. Those who engage in IDU are likely to experience stigma related to both HIV and substance use, furthering disparities among this group. A systematic literature review was conducted to examine how experiencing HIV and\/or substance use stigma was associated with attitudes towards and use of HIV continuum of care outcomes and healthcare more broadly among adults who report IDU. A systematic review utilizing the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines yielded 11 studies deemed appropriate for the current study. Experiences of stigma were examined across treatment targets (e.g., HIV prevention, ART initiation). All but two studies found that experiencing stigma was associated with poorer attitudes towards and utilization of HIV prevention and treatment. More specifically, substance use stigma was negatively associated with most HIV care continuum outcomes. A critique of the literature and directions for future research are discussed. For example, there is a need for greater consistency in stigma measurement, integrating cross-cultural and longitudinal approaches to further understand the association with the HIV care continuum among this at-risk population.<\/jats:p>","DOI":"10.1007\/s10461-026-05126-1","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T07:36:56Z","timestamp":1776411416000},"page":"3418-3429","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Association Between HIV and Substance Use Stigma and Attitudes and Utilization of HIV Care Among Adults Who Use Injection Drugs: A Systematic Review"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3534-8309","authenticated-orcid":false,"given":"T. Dylanne","family":"Twitty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"issue":"1","key":"5126_CR1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.5334\/aogh.4277","volume":"89","author":"E Kumah","year":"2023","unstructured":"Kumah E, et al. Advancing the global fight against HIV\/Aids: strategies, barriers, and the road to eradication. Ann Glob Health. 2023;89(1):83.","journal-title":"Ann Glob Health"},{"key":"5126_CR2","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.drugalcdep.2017.10.011","volume":"182","author":"SN Glick","year":"2018","unstructured":"Glick SN, et al. Increasing methamphetamine injection among non-MSM who inject drugs in King County, Washington. Drug Alcohol Depend. 2018;182:86\u201392.","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"5126_CR3","doi-asserted-by":"publisher","first-page":"e315","DOI":"10.1016\/S2352-3018(19)30036-0","volume":"6","author":"A McAuley","year":"2019","unstructured":"McAuley A, et al. Re-emergence of HIV related to injecting drug use despite a comprehensive harm reduction environment: a cross-sectional analysis. Lancet HIV. 2019;6(5):e315\u201324.","journal-title":"Lancet HIV"},{"issue":"12","key":"5126_CR4","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.annepidem.2018.06.009","volume":"28","author":"PS Sullivan","year":"2018","unstructured":"Sullivan PS, et al. Trends in the use of oral emtricitabine\/tenofovir disoproxil fumarate for pre-exposure prophylaxis against HIV infection, United States, 2012\u20132017. Ann Epidemiol. 2018;28(12):833\u201340.","journal-title":"Ann Epidemiol"},{"issue":"6","key":"5126_CR5","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1080\/09540121.2021.1913716","volume":"34","author":"KS Gordon","year":"2022","unstructured":"Gordon KS, et al. Difference in HIV testing behavior by injection status, among users of illicit drugs. AIDS Care. 2022;34(6):776\u201383.","journal-title":"AIDS Care"},{"issue":"1\u20132","key":"5126_CR6","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0899-3289(01)00072-4","volume":"13","author":"DW Purcell","year":"2001","unstructured":"Purcell DW, et al. Substance use and sexual transmission risk behavior of HIV-positive men who have sex with men. J Subst Abuse. 2001;13(1\u20132):185\u2013200.","journal-title":"J Subst Abuse"},{"issue":"1","key":"5126_CR7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12954-023-00922-7","volume":"21","author":"HA Pines","year":"2024","unstructured":"Pines HA, et al. Willingness to use and distribute HIV self-testing kits among people who inject drugs in the San Diego\u2013Tijuana border region. Harm Reduct J. 2024;21(1):4.","journal-title":"Harm Reduct J"},{"issue":"5","key":"5126_CR8","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1111\/dar.13806","volume":"43","author":"L Brener","year":"2024","unstructured":"Brener L, et al. Experiences of stigma and subsequent reduced access to health care among women who inject drugs. Drug Alcohol Rev. 2024;43(5):1071\u20139.","journal-title":"Drug Alcohol Rev"},{"key":"5126_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s10461-015-1100-4","volume":"20","author":"SK Calabrese","year":"2016","unstructured":"Calabrese SK, et al. Internalized HIV and drug stigmas: interacting forces threatening health status and health service utilization among people with HIV who inject drugs in St. Petersburg, Russia. AIDS Behav. 2016;20:85\u201397.","journal-title":"AIDS Behav"},{"issue":"12","key":"5126_CR10","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1080\/09540121.2024.2390067","volume":"36","author":"HL Surratt","year":"2024","unstructured":"Surratt HL, et al. Examining HIV pre-exposure prophylaxis (PrEP) acceptability among rural people who inject drugs: predictors of PrEP interest among syringe service program clients. AIDS Care. 2024;36(12):1858\u201368.","journal-title":"AIDS Care"},{"issue":"14","key":"5126_CR11","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1097\/QAD.0000000000002681","volume":"34","author":"SM Jenness","year":"2020","unstructured":"Jenness SM, et al. Modeling an integrated HIV prevention and care continuum to achieve the Ending the HIV Epidemic goals. AIDS. 2020;34(14):2103\u201313.","journal-title":"AIDS"},{"key":"5126_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12981-016-0120-0","volume":"13","author":"ES Kay","year":"2016","unstructured":"Kay ES, Batey DS, Mugavero MJ. The HIV treatment cascade and care continuum: updates, goals, and recommendations for the future. AIDS Res therapy. 2016;13:1\u20137.","journal-title":"AIDS Res therapy"},{"issue":"5","key":"5126_CR13","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1007\/s10461-022-03883-3","volume":"27","author":"OT Van Gerwen","year":"2023","unstructured":"Van Gerwen OT, et al. The Relationship Between HIV Pre-exposure Prophylaxis Stigma and Treatment Adherence Among Current HIV Pre-exposure Prophylaxis Users in the Southeastern U. S AIDS Behav. 2023;27(5):1478\u201385.","journal-title":"S AIDS Behav"},{"issue":"1","key":"5126_CR14","first-page":"21133","volume":"19","author":"M Sidib\u00e9","year":"2016","unstructured":"Sidib\u00e9 M, Loures L, Samb B. The UNAIDS 90-90-90 target: a clear choice for ending AIDS and for sustainable health and development. Afr J Reprod Gynaecol Endosc. 2016;19(1):21133.","journal-title":"Afr J Reprod Gynaecol Endosc"},{"issue":"4","key":"5126_CR15","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/QAI.0000000000003144","volume":"92","author":"HL Wolfe","year":"2023","unstructured":"Wolfe HL, et al. Structural equation modeling of stigma and hiv prevention clinical services among transgender and gender diverse adults: the mediating role of substance use and HIV sexual risk. JAIDS J Acquir Immune Defic Syndr. 2023;92(4):300\u20139.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"5126_CR16","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.socscimed.2015.02.018","volume":"130","author":"SE Burke","year":"2015","unstructured":"Burke SE, et al. A tale of two cities: stigma and health outcomes among people with HIV who inject drugs in St. Petersburg, Russia and Kohtla-J\u00e4rve, Estonia. Soc Sci Med. 2015;130:154\u201361.","journal-title":"Soc Sci Med"},{"issue":"3","key":"5126_CR17","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1080\/14659891.2017.1405093","volume":"23","author":"M Noroozi","year":"2018","unstructured":"Noroozi M, et al. Factors associated with HIV testing among people who inject drugs Tehran. J Subst Use. 2018;23(3):322\u20136.","journal-title":"J Subst Use"},{"issue":"6","key":"5126_CR18","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1007\/s10461-024-04308-z","volume":"28","author":"B Suprasert","year":"2024","unstructured":"Suprasert B, et al. Continuing Low Awareness and Use of Pre-exposure Prophylaxis (PrEP) for HIV among People Who Inject Drugs (PWID), San Francisco, 2022. AIDS Behav. 2024;28(6):2089\u2013100.","journal-title":"AIDS Behav"},{"issue":"3","key":"5126_CR19","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/j.1467-9566.2009.01161.x","volume":"31","author":"G Scambler","year":"2009","unstructured":"Scambler G. Health-related stigma. Sociol Health Illn. 2009;31(3):441\u201355.","journal-title":"Sociol Health Illn"},{"key":"5126_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-016-2032-4","volume":"9","author":"KE Kuchinad","year":"2016","unstructured":"Kuchinad KE, et al. A qualitative study of barriers to and facilitators of optimal engagement in care among PLWH and substance use\/misuse. BMC Res Notes. 2016;9:1\u201311.","journal-title":"BMC Res Notes"},{"key":"5126_CR21","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3389\/fpubh.2016.00062","volume":"4","author":"M Gwadz","year":"2016","unstructured":"Gwadz M, et al. Exploring how substance use impedes engagement along the HIV care continuum: a qualitative study. Front public health. 2016;4:62.","journal-title":"Front public health"},{"issue":"8","key":"5126_CR22","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1080\/09540120500330554","volume":"18","author":"NC Ware","year":"2006","unstructured":"Ware NC, Wyatt MA, Tugenberg T. Social relationships, stigma and adherence to antiretroviral therapy for HIV\/AIDS. AIDS Care. 2006;18(8):904\u201310.","journal-title":"AIDS Care"},{"issue":"3","key":"5126_CR23","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/0277-9536(94)00384-6","volume":"41","author":"AA Alonzo","year":"1995","unstructured":"Alonzo AA, Reynolds NR. Stigma, HIV and AIDS: An exploration and elaboration of a stigma trajectory. Soc Sci Med. 1995;41(3):303\u201315.","journal-title":"Soc Sci Med"},{"key":"5126_CR24","volume-title":"Stigma: notes on the management of spoiled identity","author":"E Goffman","year":"2009","unstructured":"Goffman E. Stigma: notes on the management of spoiled identity. New York: Simon and Schuster; 2009."},{"issue":"7","key":"5126_CR25","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/j.socscimed.2006.11.013","volume":"64","author":"LH Yang","year":"2007","unstructured":"Yang LH, et al. Culture and stigma: Adding moral experience to stigma theory. Soc Sci Med. 2007;64(7):1524\u201335.","journal-title":"Soc Sci Med"},{"key":"5126_CR26","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1007\/s10461-009-9593-3","volume":"13","author":"VA Earnshaw","year":"2009","unstructured":"Earnshaw VA, Chaudoir SR. From conceptualizing to measuring HIV stigma: a review of HIV stigma mechanism measures. AIDS Behav. 2009;13:1160\u201377.","journal-title":"AIDS Behav"},{"key":"5126_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-020-00399-8","volume":"17","author":"B Muncan","year":"2020","unstructured":"Muncan B, et al. They look at us like junkies: influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City. Harm Reduct J. 2020;17:1\u20139.","journal-title":"Harm Reduct J"},{"issue":"1\u20132","key":"5126_CR28","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.drugalcdep.2013.02.018","volume":"131","author":"LC Van Boekel","year":"2013","unstructured":"Van Boekel LC, et al. Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. Drug Alcohol Depend. 2013;131(1\u20132):23\u201335.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"5126_CR29","doi-asserted-by":"publisher","first-page":"782","DOI":"10.4172\/2324-9005.1000106","volume":"2","author":"M Kulesza","year":"2013","unstructured":"Kulesza M, Larimer ME, Rao D. Substance use related stigma: what we know and the way forward. J Addict Behav Ther Rehabil. 2013;2(2):782.","journal-title":"J Addict Behav Ther Rehabil"},{"issue":"7","key":"5126_CR30","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1007\/s10461-012-0347-2","volume":"17","author":"L Ti","year":"2013","unstructured":"Ti L, et al. HIV test avoidance among people who inject drugs in Thailand. AIDS Behav. 2013;17(7):2474\u20138.","journal-title":"AIDS Behav"},{"key":"5126_CR31","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.drugalcdep.2019.01.037","volume":"198","author":"DL Biancarelli","year":"2019","unstructured":"Biancarelli DL, et al. Strategies used by people who inject drugs to avoid stigma in healthcare settings. Drug Alcohol Depend. 2019;198:80\u20136.","journal-title":"Drug Alcohol Depend"},{"key":"5126_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09540121.2025.2602165","volume":"1","author":"CR Rodriguez","year":"2025","unstructured":"Rodriguez CR, et al. Interventions to enhance HIV medication adherence among individuals using substances: a systematic review and critique of the literature. AIDS Care. 2025. https:\/\/doi.org\/10.1080\/09540121.2025.2602165","journal-title":"AIDS Care"},{"key":"5126_CR33","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"issue":"2","key":"5126_CR34","doi-asserted-by":"publisher","first-page":"e0247352","DOI":"10.1371\/journal.pone.0247352","volume":"16","author":"A Belludi","year":"2021","unstructured":"Belludi A, et al. Awareness of and willingness to use pre-exposure prophylaxis (PrEP) among people who inject drugs and men who have sex with men in India: Results from a multi-city cross-sectional survey. PLoS ONE. 2021;16(2):e0247352.","journal-title":"PLoS ONE"},{"issue":"6","key":"5126_CR35","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1007\/s10461-022-03925-w","volume":"27","author":"J Owczarzak","year":"2023","unstructured":"Owczarzak J, et al. The relationship between intersectional drug use and HIV stigma and HIV care engagement among women living with HIV in Ukraine. AIDS Behav. 2023;27(6):1914\u201325.","journal-title":"AIDS Behav"},{"issue":"11","key":"5126_CR36","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1097\/QAD.0000000000003297","volume":"36","author":"EU Patel","year":"2022","unstructured":"Patel EU, et al. Drug use stigma, antiretroviral therapy use, and HIV viral suppression in a community-based sample of people with HIV who inject drugs. AIDS. 2022;36(11):1583\u20139.","journal-title":"AIDS"},{"issue":"9","key":"5126_CR37","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1007\/s10461-021-03172-5","volume":"25","author":"MV Vetrova","year":"2021","unstructured":"Vetrova MV, et al. HIV and substance use stigma, intersectional stigma and healthcare among HIV-positive PWID in Russia. AIDS Behav. 2021;25(9):2815\u201326.","journal-title":"AIDS Behav"},{"key":"5126_CR38","doi-asserted-by":"publisher","first-page":"108322","DOI":"10.1016\/j.drugalcdep.2020.108322","volume":"216","author":"KS Regenauer","year":"2020","unstructured":"Regenauer KS, et al. That person stopped being human: Intersecting HIV and substance use stigma among patients and providers in South Africa. Drug Alcohol Depend. 2020;216:108322.","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"5126_CR39","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1007\/s11904-024-00704-1","volume":"21","author":"C McGuire","year":"2024","unstructured":"McGuire C, et al. PrEP method switching: will it yield greater coverage of HIV protection? Applying lessons learned from family planning to guide future research in the context of PrEP choice. Curr HIV\/AIDS Rep. 2024;21(5):282\u201392.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"1","key":"5126_CR40","first-page":"51","volume":"22","author":"J Wogen","year":"2020","unstructured":"Wogen J, Restrepo MT. Human rights, stigma, and substance use. Health Hum Rights. 2020;22(1):51.","journal-title":"Health Hum Rights"},{"key":"5126_CR41","doi-asserted-by":"publisher","first-page":"103600","DOI":"10.1016\/j.drugpo.2022.103600","volume":"102","author":"M Vetrova","year":"2022","unstructured":"Vetrova M, et al. Stigma and ART initiation among people with HIV and a lifetime history of illicit drug use in Saint-Petersburg, Russia\u2013A prospective cohort analysis. Int J Drug Policy. 2022;102:103600.","journal-title":"Int J Drug Policy"},{"issue":"6","key":"5126_CR42","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1097\/QAD.0000000000000989","volume":"30","author":"B Joseph","year":"2016","unstructured":"Joseph B, et al. Factors associated with initiation of antiretroviral therapy among HIV-positive people who use injection drugs in a Canadian setting. Aids. 2016;30(6):925\u201332.","journal-title":"Aids"},{"issue":"4","key":"5126_CR43","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s11904-021-00556-z","volume":"18","author":"KB Biello","year":"2021","unstructured":"Biello KB, et al. The past, present, and future of PrEP implementation among people who use drugs. Curr HIV\/AIDS Rep. 2021;18(4):328\u201338.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"5126_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-019-0285-7","volume":"16","author":"S Chan Carusone","year":"2019","unstructured":"Chan Carusone S, et al. Maybe if I stop the drugs, then maybe they\u2019d care?\u2014hospital care experiences of people who use drugs. Harm Reduct J. 2019;16:1\u201310.","journal-title":"Harm Reduct J"},{"issue":"9","key":"5126_CR45","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1037\/amp0000744","volume":"75","author":"VA Earnshaw","year":"2020","unstructured":"Earnshaw VA. Stigma and substance use disorders: A clinical, research, and advocacy agenda. Am Psychol. 2020;75(9):1300.","journal-title":"Am Psychol"},{"issue":"11","key":"5126_CR46","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1111\/j.1365-3156.2010.02620.x","volume":"15","author":"R Parkes-Ratanshi","year":"2010","unstructured":"Parkes-Ratanshi R, et al. Barriers to starting ART and how they can be overcome: individual and operational factors associated with early and late start of treatment. Tropical Med Int Health. 2010;15(11):1347\u201356.","journal-title":"Tropical Med Int Health"},{"issue":"1","key":"5126_CR47","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1080\/07853890.2022.2051069","volume":"54","author":"C Mwamba","year":"2022","unstructured":"Mwamba C, et al. I need time to start antiretroviral therapy\u2019: understanding reasons for delayed ART initiation among people diagnosed with HIV in Lusaka, Zambia. Ann Med. 2022;54(1):830\u20136.","journal-title":"Ann Med"},{"issue":"7","key":"5126_CR48","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1111\/add.13348","volume":"111","author":"I Su\u00e1rez-Garc\u00eda","year":"2016","unstructured":"Su\u00e1rez-Garc\u00eda I, et al. Clinical outcomes of patients infected with HIV through use of injected drugs compared to patients infected through sexual transmission: late presentation, delayed anti\u2010retroviral treatment and higher mortality. Addiction. 2016;111(7):1235\u201345.","journal-title":"Addiction"},{"issue":"9","key":"5126_CR49","doi-asserted-by":"publisher","first-page":"e1400","DOI":"10.1016\/S2214-109X(24)00236-5","volume":"12","author":"O Stevens","year":"2024","unstructured":"Stevens O, et al. Population size, HIV prevalence, and antiretroviral therapy coverage among key populations in sub-Saharan Africa: collation and synthesis of survey data, 2010\u201323. Lancet Global Health. 2024;12(9):e1400\u201312.","journal-title":"Lancet Global Health"},{"key":"5126_CR50","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1007\/s10461-017-1758-x","volume":"21","author":"C Probst","year":"2017","unstructured":"Probst C, et al. Alcohol use, socioeconomic status and risk of HIV infections. AIDS Behav. 2017;21:1926\u201337.","journal-title":"AIDS Behav"},{"issue":"6","key":"5126_CR51","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1080\/0376835X.2019.1666703","volume":"36","author":"D Francis","year":"2019","unstructured":"Francis D, Webster E. Poverty and inequality in South Africa: critical reflections. Dev South Afr. 2019;36(6):788\u2013802.","journal-title":"Dev South Afr"},{"key":"5126_CR52","doi-asserted-by":"publisher","first-page":"S420","DOI":"10.2105\/AJPH.2021.306639","volume":"112","author":"TS Karver","year":"2022","unstructured":"Karver TS, et al. HIV-Related Intersectional Stigma and Discrimination Measurement: State of the Science. Am J Public Health. 2022;112:S420\u201332.","journal-title":"Am J Public Health"},{"key":"5126_CR53","doi-asserted-by":"publisher","first-page":"100237","DOI":"10.1016\/j.dadr.2024.100237","volume":"11","author":"A Spata","year":"2024","unstructured":"Spata A, et al. Substance use stigma: A systematic review of measures and their psychometric properties. Drug Alcohol Depend Rep. 2024;11:100237.","journal-title":"Drug Alcohol Depend Rep"},{"issue":"7","key":"5126_CR54","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1111\/j.1365-3156.2008.02091.x","volume":"13","author":"M Posse","year":"2008","unstructured":"Posse M, et al. Barriers to access to antiretroviral treatment in developing countries: a review. Tropical Med Int Health. 2008;13(7):904\u201313.","journal-title":"Tropical Med Int Health"},{"issue":"7370","key":"5126_CR55","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1136\/bmj.325.7370.954","volume":"325","author":"MM Kitahata","year":"2002","unstructured":"Kitahata MM, et al. Comprehensive health care for people infected with HIV in developing countries. BMJ. 2002;325(7370):954\u20137.","journal-title":"BMJ"},{"issue":"8","key":"5126_CR56","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1080\/17441692.2021.1934061","volume":"17","author":"CH Logie","year":"2022","unstructured":"Logie CH, et al. A scoping review of the integration of empowerment-based perspectives in quantitative intersectional stigma research. Glob Public Health. 2022;17(8):1451\u201366.","journal-title":"Glob Public Health"},{"issue":"9","key":"5126_CR57","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1080\/09540121.2016.1153595","volume":"28","author":"LM Adams","year":"2016","unstructured":"Adams LM, Balderson BH. HIV providers\u2019 likelihood to prescribe pre-exposure prophylaxis (PrEP) for HIV prevention differs by patient type: a short report. AIDS Care. 2016;28(9):1154\u20138.","journal-title":"AIDS Care"},{"issue":"5","key":"5126_CR58","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1002\/cpz1.149","volume":"1","author":"LA Cox","year":"2021","unstructured":"Cox LA, et al. Using the PhenX Toolkit to select standard measurement protocols for your research study. Curr Protocols. 2021;1(5):e149.","journal-title":"Curr Protocols"},{"issue":"9","key":"5126_CR59","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1176\/ps.2009.60.9.1254","volume":"60","author":"E Golberstein","year":"2009","unstructured":"Golberstein E, Eisenberg D, Gollust SE. Perceived stigma and help-seeking behavior: longitudinal evidence from the healthy minds study. Psychiatric Serv. 2009;60(9):1254\u20136.","journal-title":"Psychiatric Serv"},{"issue":"6","key":"5126_CR60","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1007\/s10461-024-04308-z","volume":"28","author":"B Suprasert","year":"2024","unstructured":"Suprasert B, et al. Continuing Low Awareness and Use of Pre-exposure Prophylaxis (PrEP) for HIV among People Who Inject Drugs (PWID), San Francisco, 2022. AIDS Behav. 2024;28(6):2089\u2013100.","journal-title":"AIDS Behav"},{"key":"5126_CR61","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1007\/s10461-012-0347-2","volume":"17","author":"L Ti","year":"2013","unstructured":"Ti L, et al. HIV test avoidance among people who inject drugs in Thailand. AIDS Behav. 2013;17:2474\u20138.","journal-title":"AIDS Behav"},{"issue":"8","key":"5126_CR62","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.socscimed.2008.05.032","volume":"67","author":"WT Steward","year":"2008","unstructured":"Steward WT, et al. HIV-related stigma: adapting a theoretical framework for use in India. Soc Sci Med. 2008;67(8):1225\u201335.","journal-title":"Soc Sci Med"},{"issue":"1","key":"5126_CR63","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1080\/09540120802032627","volume":"21","author":"SC Kalichman","year":"2009","unstructured":"Kalichman SC, et al. Measuring AIDS stigmas in people living with HIV\/AIDS: the Internalized AIDS-Related Stigma Scale. AIDS Care. 2009;21(1):87\u201393.","journal-title":"AIDS Care"},{"issue":"1","key":"5126_CR64","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1037\/0022-3514.76.1.114","volume":"76","author":"EC Pinel","year":"1999","unstructured":"Pinel EC. Stigma consciousness: the psychological legacy of social stereotypes. J Personal Soc Psychol. 1999;76(1):114.","journal-title":"J Personal Soc Psychol"},{"issue":"12","key":"5126_CR65","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1016\/j.socscimed.2009.04.005","volume":"68","author":"BL Genberg","year":"2009","unstructured":"Genberg BL, et al. A comparison of HIV\/AIDS-related stigma in four countries: Negative attitudes and perceived acts of discrimination towards people living with HIV\/AIDS. Soc Sci Med. 2009;68(12):2279\u201387.","journal-title":"Soc Sci Med"},{"key":"5126_CR66","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1007\/s10461-013-0437-9","volume":"17","author":"VA Earnshaw","year":"2013","unstructured":"Earnshaw VA, et al. HIV stigma mechanisms and well-being among PLWH: a test of the HIV stigma framework. AIDS Behav. 2013;17:1785\u201395.","journal-title":"AIDS Behav"},{"key":"5126_CR67","doi-asserted-by":"publisher","first-page":"103354","DOI":"10.1016\/j.drugpo.2021.103354","volume":"96","author":"EU Patel","year":"2021","unstructured":"Patel EU, et al. Drug use stigma and its association with active hepatitis C virus infection and injection drug use behaviors among community-based people who inject drugs in India. Int J Drug Policy. 2021;96:103354.","journal-title":"Int J Drug Policy"},{"issue":"11","key":"5126_CR68","doi-asserted-by":"publisher","first-page":"e39053","DOI":"10.2196\/39053","volume":"8","author":"D Kanny","year":"2022","unstructured":"Kanny D, et al. A key comprehensive system for biobehavioral surveillance of populations disproportionately affected by HIV (National HIV Behavioral Surveillance): cross-sectional survey study. JMIR Public Health Surveillance. 2022;8(11):e39053.","journal-title":"JMIR Public Health Surveillance"},{"key":"5126_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12955-017-0691-z","volume":"15","author":"M Reinius","year":"2017","unstructured":"Reinius M, et al. Development of a 12-item short version of the HIV stigma scale. Health Qual Life Outcomes. 2017;15:1\u20139.","journal-title":"Health Qual Life Outcomes"},{"key":"5126_CR70","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1007\/s10461-016-1578-4","volume":"21","author":"SR Friedman","year":"2017","unstructured":"Friedman SR, et al. Interpersonal attacks on the dignity of members of HIV key populations: a descriptive and exploratory study. AIDS Behav. 2017;21:2561\u201378.","journal-title":"AIDS Behav"},{"issue":"6","key":"5126_CR71","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/nur.10011","volume":"24","author":"BE Berger","year":"2001","unstructured":"Berger BE, Ferrans CE, Lashley FR. Measuring stigma in people with HIV: Psychometric assessment of the HIV stigma scale\u00b6. Res Nurs Health. 2001;24(6):518\u201329.","journal-title":"Res Nurs Health"},{"key":"5126_CR72","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s10862-012-9323-4","volume":"35","author":"JB Luoma","year":"2013","unstructured":"Luoma JB, et al. Self-stigma in substance abuse: Development of a new measure. J Psychopathol Behav Assess. 2013;35:223\u201334.","journal-title":"J Psychopathol Behav Assess"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-026-05126-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-026-05126-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-026-05126-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:03:10Z","timestamp":1793653390000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-026-05126-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":72,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["5126"],"URL":"https:\/\/doi.org\/10.1007\/s10461-026-05126-1","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"28 March 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"I have no conflicts of interest to disclose.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}